Originally Posted by
BlackPeter
Without drawing a pretty chart (I am sure winner has already one in the sleeves) does it look to me as if FPH is now re revenue basically back on the trendline it used to be before the recent COVID peak. Wish I could say the same about earnings, currently this bit looks a bit stalling.
Solid company, solid (revenue) growth (if we remove the COVID peak), but still pretty dear PE.
I guess the big question is - will the price pendulum move from the "too dear" into the "fair priced" territory before it moves up again?
PE still around the 40 ... not really cheap, even with a (10 yr) backward earnings CAGR of 19 ... and certainly not with a 3 yr forward earnings CAGR of 5.5;
I am wondering whether FPH might do a Ryman on us for the next handful of years ...?